Inactivated Influenza A H1N1pdm (NY/02/09)

Influenza A virus (H1N1pdm) (NY/02/09), commonly known as the 2009 pandemic H1N1 virus, is a highly contagious respiratory virus primarily transmitted through droplets expelled by coughing, sneezing, or talking. It can also be transmitted through direct contact with contaminated surfaces, where the virus can remain viable for several hours. The virus attacks epithelial cells lining the upper and lower respiratory tracts, binding to sialic acid receptors (α-2,6-linked) that are abundant in the human airways. Once inside the body, the virus replicates and disrupts host cell function, triggering an inflammatory immune response. This can cause symptoms such as fever, cough, and sore throat, and in severe cases, pneumonia or acute respiratory distress syndrome (ARDS). Notably, H1N1pdm exhibits greater pathogenicity in younger individuals, likely due to immunity in older individuals from prior exposure to antigenically related strains.

Influenza A virus (H1N1pdm) has a typical orthomyxovirus structure, with its enveloped virion studded with glycoprotein spikes—hemagglutinin (HA) and neuraminidase (NA), which mediate host cell entry and release, respectively. The HA protein of H1N1pdm (derived from a swine lineage) exhibits antigenic drift, enabling immune evasion. The virus''s segmented genome consists of eight single-stranded, negative-sense RNA segments encoding 11 proteins, including polymerase subunits (PA, PB1, PB2), nucleoprotein (NP), and nonstructural proteins (NS1, NEP). Unique reassortment of genetic segments from avian, swine, and human influenza viruses gives it pandemic potential. Specifically, the H1N1pdm strain inherits the PB1, HA, and NS segments of classical swine influenza (H1N1), the PB2 and PA segments of avian influenza viruses, and the NA and M segments of Eurasian swine influenza.